A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Toxoplasma gondii, IHC with Interpretation
Test Code19276X
CPT Codes
88342
Preferred Specimen
Formalin fixed paraffin embedded tissue in an IHC specimen transport kit
Other Acceptable Specimens
4-micron unstained slides or Fixed tissue or Tissue in neutral buffered formalin
Instructions
Pathology report is required
Transport Temperature
Room temperature
Specimen Stability
Room temperature: Indefinite
Refrigerated: Indefinite
Frozen: Unacceptable
Refrigerated: Indefinite
Frozen: Unacceptable
Methodology
Immunohistochemical Assay
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
A.M. Sets up 5 days a week.
Clinical Significance
This marker can be used to aid in the diagnosis and/or
prognosis of cancer. The clinical interpretation of any
staining or its absence should be complemented by
morphological studies using proper controls and should be
evaluated within the context of the patient's clinical
history and other diagnosis tests by a qualified
pathologist.
prognosis of cancer. The clinical interpretation of any
staining or its absence should be complemented by
morphological studies using proper controls and should be
evaluated within the context of the patient's clinical
history and other diagnosis tests by a qualified
pathologist.